Skip to content

Innovative Research on Early Recognition Model of Cognitive Impairment in Schizophrenia Based on Metabolomics Combined with Transcriptomics

Innovative Research on Early Recognition Model of Cognitive Impairment in Schizophrenia Based on Metabolomics Combined with Transcriptomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108651
Enrollment
Unknown
Registered
2025-09-03
Start date
2025-09-22
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Patient group:None
Healthy control:None

Sponsors

Tianjin Anding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patient Group: 1.Participants must meet the diagnostic criteria for "Schizophrenia" or "Schizoaffective Disorder" as defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). The diagnosis for each patient must be independently confirmed by at least two attending psychiatrists or psychiatrists of a higher professional rank. 2.Aged between 18 and 65 years. 3.No prior history of systematic antipsychotic medication treatment, and no use of any antipsychotic medication for at least two weeks prior to enrollment in this study. 4.A total score of >=60 on the Positive and Negative Syndrome Scale (PANSS). 5.Capable of cooperating to complete the cognitive function assessment (MATRICS Consensus Cognitive Battery, MCCB). 6.The patient or their legal guardian must agree to participate in this study and provide written informed consent. Healthy Control Group: 1.Healthy individuals matched with the patient group for key demographic variables such as gender and age. 2.No history of psychiatric disorders or cognitive impairment. 3.Willing to participate in this study and provide written informed consent. Healthy subjects for this study will be recruited from the community.

Exclusion criteria

Exclusion criteria: 1.Individuals who meet the DSM-5 diagnostic criteria for any mental disorder other than "Schizophrenia" or "Schizophreniform Disorder." 2.Individuals with co-occurring severe physical diseases (e.g., autoimmune diseases, metabolic syndrome) or brain organic diseases. 3.Individuals with a history of alcohol abuse or use of other psychoactive substances. 4.Women who are pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
Cognitive function;Metabolites level;

Countries

China

Contacts

Public ContactYeqing Dong

Tianjin Anding Hospital

dongyeqing@tmu.edu.cn+86 22 8818 8875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026